Morgan Stanley’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.85M Buy
603,596
+51,870
+9% +$675K ﹤0.01% 3674
2025
Q1
$5.84M Buy
551,726
+13,232
+2% +$140K ﹤0.01% 3793
2024
Q4
$9.14M Buy
538,494
+271,572
+102% +$4.61M ﹤0.01% 3479
2024
Q3
$6.2M Sell
266,922
-529,019
-66% -$12.3M ﹤0.01% 3806
2024
Q2
$19.4M Sell
795,941
-72,506
-8% -$1.77M ﹤0.01% 2705
2024
Q1
$29.3M Sell
868,447
-295,547
-25% -$9.98M ﹤0.01% 2272
2023
Q4
$36.7M Buy
1,163,994
+590,362
+103% +$18.6M ﹤0.01% 2776
2023
Q3
$14.7M Buy
573,632
+365,215
+175% +$9.33M ﹤0.01% 2766
2023
Q2
$5.98M Buy
208,417
+90,842
+77% +$2.61M ﹤0.01% 3631
2023
Q1
$2.82M Sell
117,575
-3,053
-3% -$73.2K ﹤0.01% 4238
2022
Q4
$2.05M Buy
120,628
+36,042
+43% +$611K ﹤0.01% 4449
2022
Q3
$1.25M Sell
84,586
-227,625
-73% -$3.37M ﹤0.01% 4747
2022
Q2
$4.91M Buy
312,211
+32,241
+12% +$507K ﹤0.01% 3787
2022
Q1
$7.55M Buy
279,970
+142,391
+103% +$3.84M ﹤0.01% 3237
2021
Q4
$5.09M Buy
137,579
+4
+0% +$148 ﹤0.01% 3705
2021
Q3
$6.57M Sell
137,575
-109,969
-44% -$5.25M ﹤0.01% 3392
2021
Q2
$8.38M Buy
247,544
+159,019
+180% +$5.38M ﹤0.01% 3196
2021
Q1
$3.66M Buy
88,525
+47,900
+118% +$1.98M ﹤0.01% 3736
2020
Q4
$1.76M Buy
40,625
+7,269
+22% +$315K ﹤0.01% 4264
2020
Q3
$1.43M Sell
33,356
-118,906
-78% -$5.1M ﹤0.01% 3945
2020
Q2
$7.12M Sell
152,262
-49,977
-25% -$2.34M ﹤0.01% 2303
2020
Q1
$2.75M Buy
202,239
+43,497
+27% +$591K ﹤0.01% 3060
2019
Q4
$1.73M Buy
158,742
+79,712
+101% +$867K ﹤0.01% 4148
2019
Q3
$812K Buy
79,030
+35,840
+83% +$368K ﹤0.01% 4421
2019
Q2
$408K Sell
43,190
-26,888
-38% -$254K ﹤0.01% 4709
2019
Q1
$479K Sell
70,078
-1,504
-2% -$10.3K ﹤0.01% 4563
2018
Q4
$324K Buy
71,582
+23,617
+49% +$107K ﹤0.01% 5058
2018
Q3
$424K Sell
47,965
-4,858
-9% -$42.9K ﹤0.01% 5086
2018
Q2
$448K Buy
52,823
+13,961
+36% +$118K ﹤0.01% 5173
2018
Q1
$214K Buy
38,862
+4,736
+14% +$26.1K ﹤0.01% 5438
2017
Q4
$271K Sell
34,126
-2,430
-7% -$19.3K ﹤0.01% 5297
2017
Q3
$259K Buy
36,556
+4,809
+15% +$34.1K ﹤0.01% 5222
2017
Q2
$249K Sell
31,747
-35,752
-53% -$280K ﹤0.01% 5214
2017
Q1
$539K Buy
67,499
+65,494
+3,267% +$523K ﹤0.01% 4783
2016
Q4
$29K Sell
2,005
-765
-28% -$11.1K ﹤0.01% 5896
2016
Q3
$48K Sell
2,770
-272
-9% -$4.71K ﹤0.01% 5609
2016
Q2
$96K Sell
3,042
-152
-5% -$4.8K ﹤0.01% 5258
2016
Q1
$85K Sell
3,194
-746
-19% -$19.9K ﹤0.01% 5385
2015
Q4
$173K Sell
3,940
-2,161
-35% -$94.9K ﹤0.01% 5159
2015
Q3
$258K Sell
6,101
-47
-0.8% -$1.99K ﹤0.01% 4971
2015
Q2
$282K Sell
6,148
-225
-4% -$10.3K ﹤0.01% 5071
2015
Q1
$251K Buy
6,373
+2,022
+46% +$79.6K ﹤0.01% 5083
2014
Q4
$114K Sell
4,351
-12,211
-74% -$320K ﹤0.01% 5495
2014
Q3
$1.79M Buy
16,562
+2,650
+19% +$286K ﹤0.01% 3541
2014
Q2
$1.69M Buy
13,912
+9,343
+204% +$1.13M ﹤0.01% 3625
2014
Q1
$580K Buy
4,569
+3,836
+523% +$487K ﹤0.01% 4444
2013
Q4
$92K Buy
+733
New +$92K ﹤0.01% 5375